Baker Brothers Advisors - AKARI THERAPEUTICS PLC ownership

AKARI THERAPEUTICS PLC's ticker is AKTX and the CUSIP is 00972G108. A total of 1 filers reported holding AKARI THERAPEUTICS PLC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.5%.

Quarter-by-quarter ownership
Baker Brothers Advisors ownership history of AKARI THERAPEUTICS PLC
ValueSharesWeighting
Q2 2018$115,000
-81.4%
58,770
-82.7%
0.00%
-80.0%
Q1 2018$618,000
-79.5%
339,833
-51.2%
0.01%
-80.8%
Q4 2017$3,018,000
-1.1%
696,901
+40.2%
0.03%
+4.0%
Q3 2017$3,051,000
+33.2%
496,9010.0%0.02%
+25.0%
Q2 2017$2,291,000
-58.4%
496,9010.0%0.02%
-55.6%
Q1 2017$5,501,000
+57.3%
496,9010.0%0.04%
+32.4%
Q4 2016$3,498,000
-17.3%
496,9010.0%0.03%
-10.5%
Q3 2016$4,229,000
-36.9%
496,9010.0%0.04%
-45.7%
Q2 2016$6,703,000
+20.9%
496,901
+25.5%
0.07%
+20.7%
Q1 2016$5,542,000
-3.4%
395,8820.0%0.06%
+20.8%
Q4 2015$5,740,000
-39.6%
395,8820.0%0.05%
-45.5%
Q3 2015$9,499,000395,8820.09%
Other shareholders
AKARI THERAPEUTICS PLC shareholders Q3 2023
NameSharesValueWeighting ↓
Omnia Family Wealth, LLC 467,085$761,0000.52%
Hikari Power Ltd 89,815$146,0000.02%
NEA Management Company, LLC 452,167$737,0000.01%
Truvestments Capital LLC 1,621$3,0000.00%
GEODE CAPITAL MANAGEMENT, LLC 30,264$49,0000.00%
MILLENNIUM MANAGEMENT LLC 15,276$25,0000.00%
MORGAN STANLEY 5,539$9,0000.00%
Renaissance Technologies 65,350$107,0000.00%
Citadel Advisors 37,770$62,0000.00%
HighTower Advisors, LLC 20,000$33,0000.00%
View complete list of AKARI THERAPEUTICS PLC shareholders